These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 7875433)

  • 1. [Acid secretory rebound after gastric antisecretory treatment. Above all, a problem for the physiologists!].
    Vallot T; Mignon M
    Gastroenterol Clin Biol; 1994; 18(8-9):677-9. PubMed ID: 7875433
    [No Abstract]   [Full Text] [Related]  

  • 2. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
    Gorshkov VA
    Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of gastric acidity in horses.
    Murray MJ
    J Am Vet Med Assoc; 1997 Jul; 211(1):37-40. PubMed ID: 9215408
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological control of human gastric acid secretion.
    Pounder RE
    Postgrad Med J; 1986; 62 Suppl 2():21-5. PubMed ID: 2890148
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of gastric acid rebound after stopping a successful short-term course of nizatidine in duodenal ulcer patients.
    Savarino V; Mela GS; Zentilin P; Sumberaz A; Bonifacino G; Celle G
    Am J Gastroenterol; 1991 Mar; 86(3):281-4. PubMed ID: 1671805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New antisecretory drugs in the treatment of ulcer].
    Sheptulin AA
    Klin Med (Mosk); 1994; 72(1):12-5. PubMed ID: 7910870
    [No Abstract]   [Full Text] [Related]  

  • 7. Peptic ulcer disease in the elderly.
    Cryer B; Feldman M
    Semin Gastrointest Dis; 1994 Oct; 5(4):166-78. PubMed ID: 7834250
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acid-related pathology and prolonged continuous gastric pH monitoring. Physiopathologic findings and therapeutic implications].
    Celle G; Savarino V; Mela GS
    Recenti Prog Med; 1989 Sep; 80(9):485-92. PubMed ID: 2574489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial gastric, pancreatic, and biliary response to histamine H2-receptor antagonists active duodenal ulcer.
    Longstreth GF; Go VL; Malagelada JR
    Gastroenterology; 1977 Jan; 72(1):9-13. PubMed ID: 11148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ranitidine on gastric mucus, pepsin and hydrochloric acid secretion in patients with duodenal ulcer.
    Gabryelewicz A; Sarosiek J; Laszewicz W
    Acta Med Pol; 1981; 22(4):335-9. PubMed ID: 6128866
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacology and clinical effects of acid determination in ulcer hemorrhage].
    Schepp W
    Bildgebung; 1993 Apr; 60 Suppl 1():41-4. PubMed ID: 8104063
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of H2-receptor antagonists on pepsin secretion in man.
    Gledhill T; Hunt RH
    Prog Clin Biol Res; 1985; 173():159-67. PubMed ID: 2858865
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of long-term intake of proton pump inhibitors on gastric mucosa and neuroendocrine system of gastric secretion regulation in patients with acid-dependent diseases].
    Rapoport SI; Khutsishvili MB; Rasulov MI; Trubitsina IE; Raĭkhlin NT
    Ter Arkh; 2008; 80(2):86-9. PubMed ID: 18372605
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity.
    Nielsen ST; Dove PA; Strike DP; Schiehser GA
    Drugs Exp Clin Res; 1987; 13(5):297-304. PubMed ID: 2890506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histamine H2 receptor antagonists. Pharmacology and clinical applications].
    Mignon M; Gislon J; Bonfils S
    Rev Prat; 1978 Nov; 28(53):4145-6, 4151-2, 4155-8. PubMed ID: 33441
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protection of the gastric mucosa by prostaglandins--is this physiologic concept suitable for ulcer therapy?].
    Schepp W
    Leber Magen Darm; 1986 Jan; 16(1):41-50. PubMed ID: 3959724
    [No Abstract]   [Full Text] [Related]  

  • 18. [Currents aspects of H2 receptor antagonists in the treatment of ulcers].
    Debongnie JC
    Acta Gastroenterol Belg; 1992; 55(5-6):415-22. PubMed ID: 1363166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intragastric pH modifications induced by antisecretory treatments].
    Vallot T; Galmiche JP; Gouilloud-Celle S; Mignon M
    Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):80C-87C. PubMed ID: 1680770
    [No Abstract]   [Full Text] [Related]  

  • 20. [The influence of antisecretory agents on the antral gastric mucosa in patients with duodenal ulcer].
    Rapoport SI; Raĭkhlin NT; Khutsishvili MB; Rasulov MI; Antonenko NI
    Klin Med (Mosk); 2006; 84(7):32-5. PubMed ID: 16924798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.